Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 65, Issue 3

A ten-year surveillance study of carbapenemase-producing in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates No Access

Abstract

Resistance patterns and carbapenemase gene presence among isolates from the University General Hospital of Patras, Greece during a ten-year period were analysed under a surveillance programme for multi-drug-resistant bacteria. From 2005 to 2014, isolates from clinically significant specimens were identified by the Vitek 2 Advanced Expert System. Antibiotic susceptibility testing was performed by the agar disc diffusion method and Etest. The strains were tested for the presence of , , , and genes by PCR. PFGE of chromosomal l DNA digests was performed. A total of 3449 isolates were recovered during the last decade. Among them, 1668 (48 %) were carbapenemase-producing: 1333 (80 %) carbapenemase (KPC)-, 286 (17 %) Verona imipenemase (VIM), 45 (3 %) KPC- and VIM-, and four New Delhi metallo-beta-lactamase (NDM)-producing. Their resistance rates to gentamicin, colistin and tigecycline were 41 %, 23 % and 16 %, respectively. VIM-producing were isolated in 2005 and since 2008 have been endemic. KPC-producing (KPC-Kp) isolates were introduced in 2008 and until now represent the predominant carbapenemase-producing in our institution. PFGE of 97 KPC-Kp strains identified three types: A, 84 (87 %); B, 11 (11 %); and E, two (2 %). Eleven co-producing KPC and VIM isolates belonged to PFGE B. The four NDM-positives were classified to type F. The number of bacteraemias increased during the study period, which may be solely attributed to the increase of carbapenemase-producing isolates. The threat of carbapenemase-producing emphasizes the urgent need for implementation of infection control measures and budgetary allocations to infection control.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000217
2016-03-01
2025-04-24
Loading full text...

Full text loading...

References

  1. Alicino C., Giacobbe D. R., Orsi A., Tassinari F., Trucchi C., Sarteschi G., Copello F., Del Bono V., Viscoli C., Icardi G. 2015; Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy. BMC Infect Dis 15:415 [View Article][PubMed]
     [Google Scholar]
  2. Cagnacci S., Gualco L., Roveta S., Mannelli S., Borgianni L., Docquier J. D., Dodi F., Centanaro M., Debbia E., other authors. 2008; Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak. J Antimicrob Chemother 61:296–300 [View Article][PubMed]
     [Google Scholar]
  3. EUCAST 2015; Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. European Committee on Antimicrobial Susceptibility Testing. http://www.eucast.org. Accessed 28 August 2015.
  4. Fafliora E., Bampalis V. G., Lazarou N., Mantzouranis G., Anastassiou E. D., Spiliopoulou I., Christofidou M. 2014; Bacterial contamination of medical devices in a Greek emergency department: impact of physicians’ cleaning habits. Am J Infect Control 42:807–809 [View Article][PubMed]
     [Google Scholar]
  5. Flores-Mireles A. L., Walker J. N., Caparon M., Hultgren S. J. 2015; Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269–284 [View Article][PubMed]
     [Google Scholar]
  6. Giakkoupi P., Tryfinopoulou K., Kontopidou F., Tsonou P., Golegou T., Souki H., Tzouvelekis L., Miriagou V., Vatopoulos A. 2013; Emergence of NDM-producing Klebsiella pneumoniae in Greece. Diagn Microbiol Infect Dis 77:382–384 [View Article][PubMed]
     [Google Scholar]
  7. Giakoupi P., Maltezou H., Polemis M., Pappa O., Saroglou G., Vatopoulos A., Greek System for the Surveillance of Antimicrobial Resistance. 2009; KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 14:19218[PubMed]
     [Google Scholar]
  8. Giani T., Pini B., Arena F., Conte V., Bracco S., Migliavacca R., AMCLI-CRE Survey Participants, Pantosti A., Pagani L., Luzzaro F., Rossolini G. M. 2013; Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill 18:20489
     [Google Scholar]
  9. Giani T., Arena F., Vaggelli G., Conte V., Chiarelli A., Henrici De Angelis L., Fornaini R., Grazzini M., Niccolini F., other authors. 2015; Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J Clin Microbiol 53:3341–3344 [View Article][PubMed]
     [Google Scholar]
  10. Hasan C. M., Turlej-Rogacka A., Vatopoulos A. C., Giakkoupi P., Maâtallah M., Giske C. G. 2014; Dissemination of bla VIM in Greece at the peak of the epidemic of 2005–2006: clonal expansion of Klebsiella pneumoniae clonal complex 147. Clin Microbiol Infect 20:34–37 [View Article][PubMed]
     [Google Scholar]
  11. Maltezou H. C., Giakkoupi P., Maragos A., Bolikas M., Raftopoulos V., Papahatzaki H., Vrouhos G., Liakou V., Vatopoulos A. C. 2009; Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 58:213–219 [View Article][PubMed]
     [Google Scholar]
  12. Meletis G., Oustas E., Botziori C., Kakasi E., Koteli A. 2015; Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance. New Microbiol 38:417–421[PubMed]
     [Google Scholar]
  13. Munoz-Price L. S., Poirel L., Bonomo R. A., Schwaber M. J., Daikos G. L., Cormican M., Cornaglia G., Garau J., Gniadkowski M., other authors. 2013; Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785–796 [View Article][PubMed]
     [Google Scholar]
  14. Nordmann P., Poirel L., Carrër A., Toleman M. A., Walsh T. R. 2011; How to detect NDM-1 producers. J Clin Microbiol 49:718–721 [View Article][PubMed]
     [Google Scholar]
  15. Papadimitriou-Olivgeris M., Christofidou M., Fligou F., Bartzavali C., Vrettos T., Filos K. S., Marangos M., Anastassiou E. D. 2014a; The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients. Infection 42:883–890 [View Article][PubMed]
     [Google Scholar]
  16. Papadimitriou-Olivgeris M., Marangos M., Christofidou M., Fligou F., Bartzavali C., Panteli E. S., Vamvakopoulou S., Filos K. S., Anastassiou E. D. 2014b; Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis 46:642–648 [View Article][PubMed]
     [Google Scholar]
  17. Papadimitriou-Olivgeris M., Spiliopoulou I., Christofidou M., Logothetis D., Manolopoulou P., Dodou V., Fligou F., Marangos M., Anastassiou E. D. 2015; Co-colonization by multidrug-resistant bacteria in two Greek intensive care units. Eur J Clin Microbiol Infect Dis 34:1947–1955 [View Article][PubMed]
     [Google Scholar]
  18. Papagiannitsis C. C., Tryfinopoulou K., Giakkoupi P., Pappa O., Polemis M., Tzelepi E., Tzouvelekis L. S., Vatopoulos A. C., Carbapenemase Study Group. 2012; Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals. Int J Antimicrob Agents 39:178–180 [View Article][PubMed]
     [Google Scholar]
  19. Pollett S., Miller S., Hindler J., Uslan D., Carvalho M., Humphries R. M. 2014; Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013. J Clin Microbiol 52:4003–4009 [View Article][PubMed]
     [Google Scholar]
  20. Queenan A. M., Bush K. 2007; Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20:440–458 [View Article][PubMed]
     [Google Scholar]
  21. Spyropoulou A., Bartzavali C., Vamvakopoulou S., Marangos M., Anastassiou E. D., Spiliopoulou I., Christofidou M. 2015; The first NDM metallo-β-lactamase producing Klebsiella pneumoniae isolate in a university hospital of southwestern Greece. J Chemother [View Article] [Epub ahead of print]
    [Google Scholar]
  22. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. 1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239[PubMed]
     [Google Scholar]
  23. Tsakris A., Poulou A., Pournaras S., Voulgari E., Vrioni G., Themeli-Digalaki K., Petropoulou D., Sofianou D. 2010; A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. J Antimicrob Chemother 65:1664–1671 [View Article][PubMed]
     [Google Scholar]
  24. Tzouvelekis L. S., Markogiannakis A., Psichogiou M., Tassios P. T., Daikos G. L. 2012; Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25:682–707 [View Article][PubMed]
     [Google Scholar]
  25. Vatopoulos A. 2008; High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece—a review of the current evidence. Euro Surveill 13:8023[PubMed]
     [Google Scholar]
  26. Zagorianou A., Sianou E., Iosifidis E., Dimou V., Protonotariou E., Miyakis S., Roilides E., Sofianou D. 2012; Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004–2010. Euro Surveill 17:20088[PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.000217
Loading
A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates
J. Med. Microbiol. 65, 240 (2016); https://doi.org/10.1099/jmm.0.000217
/content/journal/jmm/10.1099/jmm.0.000217
/content/journal/jmm/10.1099/jmm.0.000217
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error